ERYTHROSOMES
-
Upload
sagar-patel -
Category
Documents
-
view
107 -
download
1
Transcript of ERYTHROSOMES
ERYTHROSOMES
Pinank V. PandyaBABARIA INSTITUTE OF PHARMACY, VADODARA
INTRODUCTION
What are erythrosomes?• They are specially engineered vesicular systems
in which chemically cross-linked human erythrocyte cytoskeleton are as a support on which a lipid bilayer is coated.
• This can be achieved by modified procedure normally adopted for reverse phase evaporation.
• They are proposed as useful encapsulation system particularly for macromolecular drugs.
HISTORY
• Erythrocytes (RBCs) were discovered in 1658.• The carrier potential of these cells was first
realized in early 1970s.
They are difficult to engineer for a non RES target, but recent innovation based on biophysically devices may render them suitable for targeting to organs other than RES. (Juliano,1980; DeLoach et al, 1991; Vyas & Jain, 1994)
Why erythrosome?
The desirable properties, which substantiate stability of RBCs as drug carrier are:-
• Biodegradability• Circulate through circulatory system.• Large volume of material can be encapsulated.• can be utilized for organ targeting with in RES.• A wide variety of bioactive agents can be
encapsulated within them.• Biocompatibility.
METHOD OF PREPARATION
ISOLATION OF ERYTHROCYTES :
-SOURCE :- Different mammalian RBCs have been exploited for drug loading. Majority of them constructed for RBCs of mice, cattle, pigs, dogs, sheep, goats, monkeys, chicken, rats & rabbits.
-ISOLATION:- Blood is collected in heparinized tubes by vein puncture (EDTA or heparin can be used as anti coagulant). Fresh RBCs are preffered because of their higher encapsulation efficiency.
• RBCs are harvested & washed by centrifugation. According to source centrifugal force & washing fluid is changed.
-General conditions:-• Centrifugation-2000 RPM for 5 min at 4*C• Buffer solution(washing fluid):• NaCl -14 mmol/L • KCl -16 mmol
• MgCl2 -4 mmol
• CaCl2 -2 mmol
Tris -5 mmol
RBC s are often stored in acid-citrate-dextrose buffer at 4*C upto 48h prior to use.
METHOD OF DRUG LOADING :
Mostly hypotonic lysis of cell in a solution containing drug/enzyme to be entrapped followed by restoration of tonicity to reseal them serves as a loading procedure.
other techniques such as electrical breakdown, endocytosis, chemical purturbation of membrane & lipid erythrocyte fusion have also been utilised.
SHELF & STORAGE STABILITY OF ERYTHROSOMES
It is a major challenge in the their practical utility as DDS.
• Lewis & alpar, 1984 have reported that encapsulated product & carrier both exhibit satisfactory shelf stability, when stored in Hank’s balanced salt solution (HBBS)at 4*C for 2 weeks.
• Similar results were obtained by suspending cells in oxygenated HBBS containing 1% soft bloom gelatin.
• The cells are well recovered after liquefying the gel by placing the tube in water bath at 37*C followed by centrifugation.
• Under clinical condition standard blood bags may be used for both encapsulation & storage.
• The procedure would be to used group ‘O’(universal donor) cells by preswell or dialysis technique.
• Another method utilized for storage has been the cryopreservation of RBCs in liquid nitrogen.
IN VIVO SURVIVAL AND IMMUNOLOGICAL CONSEQUENCES• A bimodel type of survival kinetic is observed :
A rapid loss of cell during first 24 h followed much slower release after word.
• The early loss that accounts for 15% of total population represents the cells that are severly damaged during drug loading.
• The inter subject & inter species variation from different sources require ajudicial analysis &use of the source before experiment is designed.
• There three general modes of efflux of loaded drug from erythrosome.
-phagocytosis
-diffusion
-specific transport mechanism• The phagocytosis occurs within RES.• The degree of cross linking determines
whether spleen or liver will preferentially remove the cell.
• It is observed that erythrocyte carriers constructed from analogous sources do not elicit an immunological consequences.
BIOMEDICAL APPLICATIONS OF ERYTHROSOMES
(1) Erythrosomes as carriers of enzymes:-
-ideal carriers of enzymes in inherited metabolic diseases.
-enzymes that are usually carried are
catalase , urease , uricase , invertase, arginase , asparaginase , glucuronidase , galactosidase etc.
e.g. alcohol dehydrogenase & acetaldehyde dehydrogenase encapsulated in human RBCs used in vivo for complete metabolism of ethanol.
(2) Erythrosomes as carrier of drugs
-slow and sustained release of drugs in treatment of paracytic disease.
-erythrosomes serves as ideal carrier for antineoplastic agents like bleomycin, actinomycin-D, adriamycin or cytosin arabinoside.
-vitamins & steroids have also been encapsulated in erythrosomes.
(3) As carriers of proteins & macromolecules
-Bird et al.1983 proposed erythrocytes as carrier for insulin for its sustain release.
-erythrosomes may serve as cellular sustain delivery system for in vivo administration of recombinant human erythropoeitin.
-RBCs coated with recombinant interlukin-2 (rIL-2) are reported to provide sustain delivery so as to allow low and non toxic concentrations of IL-2 in circulation.
(4) Drug targeting
-osmotically loaded ehrocytes can act as drug carrier in systemic circulation.
-chemically surface modified erythrocytes are targeted to organ of the mononuclear phagocytic system /reticular endothelial system because changes incorporated in membrane that are recognized by macrophage cell.
Treatment of paracytic disease
-paracytic disease in which paracyte reside in RES have been effectively treated with erythrosomes.
-Pentamidine primaquine phosphate & metronidazole have been successfully utilized for treatment of leishmaniasis, malaria, extra intestinal amoebiasis on exp. Laboratory models.
• Targeting in areas other than RES using:
-paramagnetic particle loaded RBCs.
-photosensitive element loaded RBCs.
-ultra sound waves.
-target specific immunoglobulin attached to RBCs.
(5)In oxygen deficiency therapy erythrocytes are used in case of oxygen
deficiency where an improved oxygen supply is required as in following cases:
-high altitude condition (where oxygen partial pressure is low)
-small number of alveoli -increased resistance to oxygen diffusion in lungs -increased radio sensitivity in of radiation sensitive tumors -liver mediated detoxification process where an increased oxygen supply is
required.
- Inositol hexaphosphate (IHP, phytic acid) loaded in RBCs binds irreversibly to hemoglobin & reduces its oxygen binding, thus releasing same in capillaries.
(6) Erythrosomes in cell biological application microinjection of macromolecules into cultured
cells using erythrocyte ghosts :
-using either Sendai virus (haemagglutinating virus of
Japan, HVJ) or PEG mediated fusion, & then macromolecules are transferred efficiently from cytoplasm to nucleus of their expression.
-erythrocyte ghost cell fusion (microinjection) method mediated HVJ is relatively easier, & can be used for microinjection in many cells at the same time.
(7) Cell biological application
-fragment A of diphtheria toxin (which on entering cytoplasm inhibits peptide chain elongation in translation &causing cell death) can be introduced in to target cell by erythrocyte ghost cell fusion.
FUTURE PERSPECTIVE
• A large amount of valuable work is needed so as to utilize the potential of erythrocytes in passive as well as active targeting of drugs.
• Diseases like cancer can surely find its cure
• Genetic engineering aspects can be coupled to give newer dimension to the existing drug cellular concept.